Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer

Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer

In previous clinical studies, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in cancer patients has a high risk of aggravation and mortality than in healthy infected individuals. Inoculation with coronavirus disease 2019 (COVID-19) vaccine reduces the risk of SARS-CoV-2 infec...

Full description

Bibliographic Details
Main Authors: Takuma Hayashi, Kenji Sano, Nobuo Yaegashi, Ikuo Konishi
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Current Issues in Molecular Biology
Subjects:
SARS-CoV-2
COVID-19
micrometastatic niche
patient with cancer
Online Access:https://www.mdpi.com/1467-3045/44/12/400

Internet

https://www.mdpi.com/1467-3045/44/12/400

Similar Items